[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antiandrogen Monotherapy Market Professional Survey Report Forecast 2017-2022

July 2017 | 112 pages | ID: GE9A2A54229EN
S&P Consulting

US$ 2,720.00 US$ 3,400.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

This report studies Antiandrogen Monotherapy in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

By types, the market can be split into
  • Type 1
  • Type 2
  • Type 3
By Application, the market can be split into
  • Application 1
  • Application 2
  • Application 3
By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India
1 INDUSTRY OVERVIEW OF ANTIANDROGEN MONOTHERAPY

1.1 Definition and Specifications of Antiandrogen Monotherapy
  1.1.1 Definition of Antiandrogen Monotherapy
  1.1.2 Specifications of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Antiandrogen Monotherapy
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTIANDROGEN MONOTHERAPY

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antiandrogen Monotherapy
2.3 Manufacturing Process Analysis of Antiandrogen Monotherapy
2.4 Industry Chain Structure of Antiandrogen Monotherapy

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTIANDROGEN MONOTHERAPY

3.1 Capacity and Commercial Production Date of Global Antiandrogen Monotherapy Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Antiandrogen Monotherapy Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Antiandrogen Monotherapy Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Antiandrogen Monotherapy Major Manufacturers in 2016

4 GLOBAL ANTIANDROGEN MONOTHERAPY OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Antiandrogen Monotherapy Capacity and Growth Rate Analysis
  4.2.2 2016 Antiandrogen Monotherapy Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Antiandrogen Monotherapy Sales and Growth Rate Analysis
  4.3.2 2016 Antiandrogen Monotherapy Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Antiandrogen Monotherapy Sales Price
  4.4.2 2016 Antiandrogen Monotherapy Sales Price Analysis (Company Segment)

5 ANTIANDROGEN MONOTHERAPY REGIONAL MARKET ANALYSIS

5.1 North America Antiandrogen Monotherapy Market Analysis
  5.1.1 North America Antiandrogen Monotherapy Market Overview
  5.1.2 North America 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.1.4 North America 2016 Antiandrogen Monotherapy Market Share Analysis
5.2 China Antiandrogen Monotherapy Market Analysis
  5.2.1 China Antiandrogen Monotherapy Market Overview
  5.2.2 China 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.2.4 China 2016 Antiandrogen Monotherapy Market Share Analysis
5.3 Europe Antiandrogen Monotherapy Market Analysis
  5.3.1 Europe Antiandrogen Monotherapy Market Overview
  5.3.2 Europe 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.3.4 Europe 2016 Antiandrogen Monotherapy Market Share Analysis
5.4 Southeast Asia Antiandrogen Monotherapy Market Analysis
  5.4.1 Southeast Asia Antiandrogen Monotherapy Market Overview
  5.4.2 Southeast Asia 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.4.4 Southeast Asia 2016 Antiandrogen Monotherapy Market Share Analysis
5.5 Japan Antiandrogen Monotherapy Market Analysis
  5.5.1 Japan Antiandrogen Monotherapy Market Overview
  5.5.2 Japan 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.5.4 Japan 2016 Antiandrogen Monotherapy Market Share Analysis
5.6 India Antiandrogen Monotherapy Market Analysis
  5.6.1 India Antiandrogen Monotherapy Market Overview
  5.6.2 India 2012-2017 Antiandrogen Monotherapy Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Antiandrogen Monotherapy Sales Price Analysis
  5.6.4 India 2016 Antiandrogen Monotherapy Market Share Analysis

6 GLOBAL 2012-2017 ANTIANDROGEN MONOTHERAPY SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Antiandrogen Monotherapy Sales by Type
6.2 Different Types of Antiandrogen Monotherapy Product Interview Price Analysis
6.3 Different Types of Antiandrogen Monotherapy Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Antiandrogen Monotherapy Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Antiandrogen Monotherapy Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Antiandrogen Monotherapy Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Antiandrogen Monotherapy Growth Driving Factor Analysis
  6.3.5 Other of Antiandrogen Monotherapy Growth Driving Factor Analysis

7 GLOBAL 2012-2017 ANTIANDROGEN MONOTHERAPY SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Antiandrogen Monotherapy Consumption by Application
7.2 Different Application of Antiandrogen Monotherapy Product Interview Price Analysis
7.3 Different Application of Antiandrogen Monotherapy Product Driving Factors Analysis
  7.3.1 Office Use of Antiandrogen Monotherapy Growth Driving Factor Analysis
  7.3.2 Personal Use of Antiandrogen Monotherapy Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTIANDROGEN MONOTHERAPY

8.1 Pfizer Inc. (USA)
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Abbott Laboratories (USA)
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Genentech Inc. (USA)
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 GlaxoSmithKline Plc (UK)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Immunomedics, Inc. (USA)
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Indevus Pharmaceuticals Inc. (USA)
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Novartis AG (Switzerland)
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 OSI Pharmaceuticals, Inc. (USA)
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Paladin Labs Inc. (Canada)
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

...

9 DEVELOPMENT TREND OF ANALYSIS OF ANTIANDROGEN MONOTHERAPY MARKET

9.1 Global Antiandrogen Monotherapy Market Trend Analysis
  9.1.1 Global 2017-2022 Antiandrogen Monotherapy Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Antiandrogen Monotherapy Sales Price Forecast
9.2 Antiandrogen Monotherapy Regional Market Trend
  9.2.1 North America 2017-2022 Antiandrogen Monotherapy Consumption Forecast
  9.2.2 China 2017-2022 Antiandrogen Monotherapy Consumption Forecast
  9.2.3 Europe 2017-2022 Antiandrogen Monotherapy Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Antiandrogen Monotherapy Consumption Forecast
  9.2.5 Japan 2017-2022 Antiandrogen Monotherapy Consumption Forecast
  9.2.6 India 2017-2022 Antiandrogen Monotherapy Consumption Forecast
9.3 Antiandrogen Monotherapy Market Trend (Product Type)
9.4 Antiandrogen Monotherapy Market Trend (Application)

10 ANTIANDROGEN MONOTHERAPY MARKETING TYPE ANALYSIS

10.1 Antiandrogen Monotherapy Regional Marketing Type Analysis
10.2 Antiandrogen Monotherapy International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antiandrogen Monotherapy by Regions
10.4 Antiandrogen Monotherapy Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTIANDROGEN MONOTHERAPY

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 APPENDIX
LIST OF TABLES AND FIGURES

FIGURE PICTURE OF ANTIANDROGEN MONOTHERAPY


Table Product Specifications of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure Global Production Market Share of Antiandrogen Monotherapy by Type in 2016
Table Applications of Antiandrogen Monotherapy
Figure Global Consumption Volume Market Share of Antiandrogen Monotherapy by Application in 2016
Figure Market Share of Antiandrogen Monotherapy by Regions
Figure North America Antiandrogen Monotherapy Market Size (2012-2022)
Figure China Antiandrogen Monotherapy Market Size (2012-2022)
Figure Europe Antiandrogen Monotherapy Market Size (2012-2022)
Figure Southeast Asia Antiandrogen Monotherapy Market Size (2012-2022)
Figure Japan Antiandrogen Monotherapy Market Size (2012-2022)
Figure India Antiandrogen Monotherapy Market Size (2012-2022)
Table Antiandrogen Monotherapy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antiandrogen Monotherapy in 2016
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Industry Chain Structure of Antiandrogen Monotherapy
Table Capacity and Commercial Production Date of Global Antiandrogen Monotherapy Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Antiandrogen Monotherapy Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Antiandrogen Monotherapy Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Antiandrogen Monotherapy Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Antiandrogen Monotherapy 2012-2017
Figure Global 2012-2017 Antiandrogen Monotherapy Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Antiandrogen Monotherapy Market Size (Value) and Growth Rate
Table 2012-2017 Global Antiandrogen Monotherapy Capacity and Growth Rate
Table 2016 Global Antiandrogen Monotherapy Capacity List (Company Segment)
Table 2012-2017 Global Antiandrogen Monotherapy Sales and Growth Rate
Table 2016 Global Antiandrogen Monotherapy Sales List (Company Segment)
Table 2012-2017 Global Antiandrogen Monotherapy Sales Price
Table 2016 Global Antiandrogen Monotherapy Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure North America 2012-2017 Antiandrogen Monotherapy Sales Price
Figure North America 2016 Antiandrogen Monotherapy Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure China 2012-2017 Antiandrogen Monotherapy Sales Price
Figure China 2016 Antiandrogen Monotherapy Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure Europe 2012-2017 Antiandrogen Monotherapy Sales Price
Figure Europe 2016 Antiandrogen Monotherapy Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure Southeast Asia 2012-2017 Antiandrogen Monotherapy Sales Price
Figure Southeast Asia 2016 Antiandrogen Monotherapy Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure Japan 2012-2017 Antiandrogen Monotherapy Sales Price
Figure Japan 2016 Antiandrogen Monotherapy Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Antiandrogen Monotherapy 2012-2017
Figure India 2012-2017 Antiandrogen Monotherapy Sales Price
Figure India 2016 Antiandrogen Monotherapy Sales Market Share
Table Global 2012-2017 Antiandrogen Monotherapy Sales by Type
Table Different Types Antiandrogen Monotherapy Product Interview Price
Table Global 2012-2017 Antiandrogen Monotherapy Sales by Application
Table Different Application Antiandrogen Monotherapy Product Interview Price
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Global Market Share (2012-2017)
Figure Global 2017-2022 Antiandrogen Monotherapy Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2022 Antiandrogen Monotherapy Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2022 Antiandrogen Monotherapy Sales Price Forecast
Figure North America 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Figure China 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Figure India 2017-2022 Antiandrogen Monotherapy Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Antiandrogen Monotherapy by Types 2017-2022
Table Global Consumption Volume of Antiandrogen Monotherapy by Applications 2017-2022
Table Traders or Distributors with Contact Information of Antiandrogen Monotherapy by Regions


More Publications